Canagliflozin Alternatives in District of Columbia
Compare generic and therapeutic alternatives to Canagliflozin (canagliflozin) available at District of Columbia pharmacies. Save up to 48% on your prescription — no insurance required.
Top Alternatives in District of Columbia
Metformin
therapeutic
First-line T2D medication — dramatically cheaper
Avg cash price: $8/mo
Dapagliflozin (Farxiga)
therapeutic
Competing SGLT2 inhibitor with similar profile
Avg cash price: $530/mo
Empagliflozin (Jardiance)
therapeutic
SGLT2 inhibitor with strong cardiovascular outcomes data
Avg cash price: $560/mo
District of Columbia Prescription Assistance Programs
DC Medicaid Rx (DC Health Care Alliance)
Prescription drug coverage for DC Medicaid beneficiaries and uninsured DC residents with incomes up to 200% FPL through the DC Health Care Alliance program.
Eligibility: Low-income DC residents including adults up to 215% FPL for Medicaid, and uninsured adults through the Alliance program.
DCPAP (DC Pharmaceutical Assistance Program)
Assists eligible low-income DC seniors with Medicare Part D co-payments and coverage gaps.
Eligibility: DC residents aged 65+ enrolled in Medicare Part D with income at or below 300% FPL. Contact the DC Office on Aging at 202-724-5622.
Frequently Asked Questions
Is there a generic for canagliflozin (Invokana)?
Not yet as of 2025. Canagliflozin is still under brand exclusivity as Invokana. All SGLT2 inhibitors remain brand-only at similar high prices.
How does canagliflozin compare to other SGLT2 inhibitors?
Canagliflozin, dapagliflozin, and empagliflozin have similar glucose-lowering effects. Differences emerge in cardiovascular and renal outcomes data — your cardiologist or endocrinologist guides the choice.
What is the main risk specific to canagliflozin?
Canagliflozin carries an FDA warning about increased risk of lower-limb amputations, particularly in patients with peripheral vascular disease. Discuss your individual risk with your doctor.
Can Script Unlock help with canagliflozin costs?
While there is no generic, Script Unlock pharmacies sometimes offer lower cash-pay brand pricing. It is worth posting your script to compare bids.
Is metformin a good alternative to canagliflozin for T2D?
Metformin is first-line T2D therapy at under $10/month. SGLT2 inhibitors like canagliflozin are added for patients who need additional cardiovascular or renal benefits beyond glucose lowering.